Bank of New York Mellon’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,620
Closed -$39.4K 4167
2023
Q4
$39.4K Hold
1,620
﹤0.01% 4179
2023
Q3
$32.7K Sell
1,620
-8
-0.5% -$205 ﹤0.01% 4209
2023
Q2
$48K Sell
1,628
-9,409
-85% -$268K ﹤0.01% 4184
2023
Q1
$276K Sell
11,037
-170
-2% -$5.47K ﹤0.01% 3781
2022
Q4
$355K Buy
11,207
+227
+2% +$7.15K ﹤0.01% 3719
2022
Q3
$326K Buy
10,980
+1,550
+16% +$53.5K ﹤0.01% 3789
2022
Q2
$287K Sell
9,430
-1,052
-10% -$96.4K ﹤0.01% 3906
2022
Q1
$1.42M Buy
10,482
+96
+0.9% +$10.1K ﹤0.01% 3110
2021
Q4
$1.35M Buy
10,386
+646
+7% +$81.7K ﹤0.01% 3213
2021
Q3
$914K Buy
9,740
+1,413
+17% +$144K ﹤0.01% 3440
2021
Q2
$853K Buy
8,327
+4,759
+133% +$831K ﹤0.01% 3514
2021
Q1
$656K Sell
3,568
-429
-11% -$94.6K ﹤0.01% 3544
2020
Q4
$1.37M Buy
+3,997
New +$943K ﹤0.01% 3061

Other funds holding LONA

Bank of New York Mellon's LONA Position: Q1 2024 in Review

Bank of New York Mellon sold out of LeonaBio Inc (LONA) in Q1 2024, closing a stake of 1,620 shares — an estimated $39.4K sold.

Bank of New York Mellon first reported a position in LONA in Q4 2020 and held it in 13 quarters. The position peaked at $1.42M in Q1 2022. 75 funds tracked by Wall St. Rank hold LONA as of Q1 2024.

  • Bank of New York Mellon reported no remaining LeonaBio Inc position as of Q1 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 1,620 LeonaBio Inc shares in Q1 2024, an estimated $39.4K.
  • Bank of New York Mellon first reported a position in LeonaBio Inc in Q4 2020 and held it in 13 quarters.
  • Bank of New York Mellon's LeonaBio Inc position peaked at $1.42M in Q1 2022.
  • 75 funds tracked by Wall St. Rank held LeonaBio Inc as of Q1 2024.

Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.